CONCLUSION Although more research and consensus are needed to determine the optimal length of time for holding GLP-1 receptor agonists before a procedure requiring anesthesia, it is important for practitioners and patients to be aware of the increased risks for aspiration and to consider strategies to mitigate harm
Among these, BPC-157 (Body Protection Compound-157), a synthetic peptide derived from a protective protein found in gastric juice, has garnered significant attention for its remarkable regenerative and anti-inflammatory properties
Moreover, our study revealed that GLP-1 analogs, including GLP-1, liraglutide, and exendin-4, along with the GLP-1 antagonist exendin 939, derived from exendin-4, which shares 53% sequence homology with native GLP-1 39 , effectively inhibited CAP-induced TRPV1 activation in mouse DRG neurons
Together, these facilitate weight loss
This is not only about improving the lives of people as they age, but also about decreasing the stress on our health care systems